Hangzhou MacroLink Biopharmaceutical LLC
Hangzhou MacroLink Biopharmaceutical LLC
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 | Advanced Esophageal Cancer; Advanced Lung Cancer | Not yet recruiting | Phase 1 | 2026-07-27 | NCT07726212 |